## **Trustee Annual Report** ## **Afridi Brothers Society Charity No: 1182388** ## **Covering the period 1 April 2021 to 31 March 2022** The charity was formed on 8[th] March 2019 as a charitable incorporated organisation, governed by a constitution. The purposes of the charity are to relieve and protect the health of sufferers of Duchenne Muscular Dystrophy (DMD) During the year, the charity spent £21,146 on such activities. A summary of the financial position of the charity is attached to this report. The following individuals served as charity trustees during the year and continued as trustees on the date on which this report was signed. ## Mr. Hamza Afridi - Mr. Dermot Purcell FCA - Mr. Muhammad Kamran Khan Durrrani - Mr. Julius Robert Harry Sweetland **Approved on 3[rd] March 2023** **___________________** **Hamza Afridi** **___________________** **Dermot Purcell** ||**Afridi Brpthers Society**|**Afridi Brpthers Society**|**Afridi Brpthers Society**|**Afridi Brpthers Society**|**CC16a**| |---|---|---|---|---|---| ||||||| ||**For the period**
**from**|01/04/2021|**To**||| ||||||| ||||||| |**Section A Receipts and payments**|||||| |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**100**
**-**
**-**
**-**
**-**
**-**
**-**
**-**

**100**
**-**
**-**
**-**
**100**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**100**
**-**
**684**
**784**|**Restricted**
**funds**
**to the nearest £**
**5**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**5**
**-**
**-**
**-**
**5**
**21,147**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**21,147**
**-**
**-**
**-**
**21,147**
**- 21,142**
**-**
**30,000**
**8,858**|**Endowment**
**funds**
**to the nearest £**|**Total funds**
**to the nearest £**
**105**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**105**
**-**
**-**
**-**
**105**
**21,147**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**21,147**
**-**
**-**
**-**
**21,147**
**- 21,042**|**Last year**
**to the nearest £**| |Compensation|**100**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**30,684**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| |**_Sub total_**_(Gross income for_
_AR)_|
**100**||||**30,684**| ||||||| |**A2 Asset and investment sales,**
**(see table).**|||||| ||**-**||**-**
**-**
**-**||| ||**-**||||**-**| |**_Sub total_**|**-**||||**-**| |**_Total receipts_**
**A3 Payments**|||||| ||||**-**||**30,684**| ||||||| |
Project Pakistan|**-**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| ||**-**||||**-**| |**_Sub total_ **|**-**||||**-**| ||||||| |**A4 Asset and investment**
**purchases (see table)**|||||| |**,**|**-**||**-**
**-**
**-**||| ||**-**||||| |**_Sub total_ **|**-**||||**-**| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||| ||||**-**||**-**| ||||||| ||**100**||**-**||**30,684**| ||**-**||**-**
**-**|**-**
**30,684**|**-**| ||**684**||||**-**| ||**784**||**-**|**9,642**|**30,684**| CCXX R1 accounts (SS) 05/03/2023 1 |**Section B Statement of assets and liabilities at**|**Section B Statement of assets and liabilities at**|**the end of the period**|| |---|---|---|---| |**Categories**|**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
**Details**
**Details**
Signature|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**784**
8,858
**-**
**-**
**-**
**-**
**784**
**8,858**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
Hamza Afridi
Dermot Purcell|**Endowment**
**funds**
**to nearest £**| |Signed by one or two trustees on
behalf of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|||| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| ||||03/03/2023| ||||03/03/2023| ||||| CCXX R2 accounts (SS) 05/03/2023 2